This type of constipation may be associated with elevated psychosocial distress
A researchers guide to preclinical mouse NASH models
Run it through the state board portal
GLP-1 prescriptions increase by 364% whilst BMS declines by 42% owenhaskins May 28, 2025 5 min read Over two percent of adult patients now take a GLP-1 drug to treat overweight or obesity, according to a FAIR Health white paper entitled, Obesity and GLP-1 Drugs: A Claims-Based Analysis
Crucially, microbial diversity was not disrupted, which matters because broad antimicrobial disruption of the axillary microbiome can backfire by creating ecological niches for worse bacteria
How Semaglutide Improves Sleep Quality Beyond Weight Loss Beyond weight reduction, emerging evidence suggests GLP-1 agonists may improve sleep architecture through metabolic and inflammatory pathways